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Summary: Fractionation of alkaline phosphatase isoenzymes and isoforms by isoelectric focusing is a simple
procedure that resolves up to 17 fractions having alkaline phosphatase activity. The fractions are stable at 4 °C, and
undergo only slight changes during repeated freeze-thaw cycles. Petreatment with phospholipase-C or sialidase
changes the isoelectric focusing patterns of alkaline phosphatase in serum; we recommend they not be used owing
to the loss of information. We found that the alkaline phosphatase fractions provide diagnostic information in
addition to that given by the common liver-function tests in patients with chronic liver diseases. Primary biliary
cirrhosis and primary sclerosing cholangitis showed similar biochemical changes, but they are very different from
alcoholic cirrhosis based on the common liver-function tests and the alkaline phosphatase isoform patterns obtained
by isoelectric focusing. Analysis of the laboratory data using neural networks has some limited use in distinguishing
chronic and chronic-active hepatitis of any cause. We have confirmed the tissue assignments made by Griffiths
(Prog Clin Biochem 1989; 8:63—74) for the alkaline phosphatase fractions in liver as obtained by isoelectric
focusing: Fractions la and Ib show a strong correlation with biliary diseases, and fractions 2, 3, and 4 show
consistent increases in patients with primary disorders of hepatocytes; these fractions have good sensitivity for
hepatocyte injury, but their specificity is limited. Fraction 10 may be a marker of activated T-lymphocytes; it was
abnormal in most of our patients suggesting that it is a sensitive but non-specific test. Analysis of alkaline phospha-
tase by isoelectric focusing deserves further evaluation, because it may facilitate the diagnosis of certain chronic
liver disorders and could be a supplement to the biopsy.
Introduction
Griffiths suggested that the hepatic isoforms and band
10 of alkaline phosphatase1) in serum may serve as a
"biochemical biopsy" in patients with liver diseases
(1). Fractionating alkaline phosphatase subspecies by
partial inactivation with heat, zone electrophoresis,
polyacrylamide disk-gel electrophoresis, and the use
of lectins to inhibit the bone fraction increases the
information content of the test and may reveal the
cause of an abnormality (2). Griffiths showed that
isoelectric focusing separates alkaline phosphatase
from serum into 17 or more fractions and proposed a
system of fraction identification (1). We reported the
isoelectric focusing findings in patients following or-
thotopic liver transplantation and found that mem-
brane-associated-, liver-, and lipoprotein-bound alka-
line phosphatase or high molecular mass alkaline
!) Enzymes:
Alanine aminotransferase, EC 2.6.1.2;
Alkaline phosphatase, EC 3.1.3.1;
Aspartate aminotransferase, EC 2.6.1.1;
Phospholipase C, phpsphatidylinositol-specific, EC 3.1.4.3;
Sialidase, EC 3.2.1.18.
phosphatase, are significantly higher in patients with
complications as compared to those with a stable post-
operative course (3). In patients with liver diseases,
there is now evidence that alkaline phosphatase frac-
tions la and Ib reflect primary or secondary biliary
ductule injury of various causes. Patients with obstruc-
tive biliary tract disease such as primary biliary cirrho-
sis or primary sclerosing cholangitis often have a
marked increase in alkaline phosphatase fractions la
and Ib during the acute phase of these disorders.
Increases in fraction 2 are expected in cases of hepato-
cyte injury of any cause, late cholestasis, other ob-
structive disorders, or following exposure to hepato-
toxic agents. Fraction 3 is believed to originate from
the reticuloendothelial cells derived from any site of
origin, and fraction 4 is associated with the vascular
endothelium such as capillaries and arterioles. Frac-
tions 5, 6, 7, 8, 9, and 11 have as yet an undefined
association with liver pathology; band 5 has been re-
ported to originate from bone (1, 4). Fraction 10 is
found in placental trophoblasts and activated T-lym-
phocytes; increases in fraction 10 would be expected
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in any autoimmune processes or other causes of lym-
phocyte infiltration of the liver as is found in many
recipients of transplanted livers.
Goals
We had several broad goals in this study. The most im-
portant was to identify the abnormalities of alkaline
phosphatase fractions by isoelectric focusing in patients
with well-defined chronic liver diseases. We included in
this discovery process other commonly performed liver-
function tests in serum such as total alkaline phospha-
tase, alanine aminotransferase1), aspartate aminotrans-
ferase1), and total bilirubin. Other test results such as
the prothrombin time, activated partial thromboplastin
time, serum albumin, serum protein electrophoresis, vi-
ral serologies, auto-antibodies, and liver biopsy results
were also collected. A secondary goal was to apply sta-
tistical tools to the alkaline phosphatase fractions and
liver-function tests data in an attempt to discover any




Patients visiting our Hepatology Clinic during a period of about 18
months and who were found clinically to have chronic liver dis-
eases were included. The 162 unique patients were identified by
one of us (RBK) for inclusion in the cohort; most of the patients
had results from liver biopsies in their medical record.
Laboratory tests including alkaline phosphatase
fractions by isoelectric focusing
Serum specimens, left over from routine testing of in- and
outpatients, were obtained from The Ohio State University Hos-
pitals Clinical Chemistry Laboratory. Liver-function tests and
isoelectric focusing were performed immediately to minimize
the possibility of enzyme loss. Alkaline phosphatase, aspartate
aminotransferase, alanine aminotransferase, and total bilirubin
were analyzed on a Johnson & Johnson (Rochester, NY 14650,
U. S. A.) Ektachem 700® analyzer. Isoelectric focusing of alka-
line phosphatase isoforms was performed using the Resolve®-
ALP 90-test kit, the Resolve Omega electrophoresis power sup-
ply and cells, a computerized densitometric scanner, and a 2000
volt power supply, all from Isolab, Akron, OH 44321, USA,
according to the manufacturer's directions. The 1% agarose gels
were 0.85 mm thick and contained 25 ml/1 ampholytes that
established a pH gradient of 3 to 10 during electrophoresis. The
application template was placed 1 cm toward the cathodal side
from the center of the gel, and the distance between the wires
that contact the filter-paper bridges in the cell was 8 cm. We
used a 75-minute electrofocusing time throughout. Minor devia-
tions from the manufacturer's instructions are described else-
where (3). Phospholipase C and sialidase, also known as neur-
aminidase, were obtained in kit form from Isolab, and the manu-
facturer's instructions for their use were followed exactly.
Results and Discussion
Figure 1 is a schematic of high-resolution isoelectric fo-
cusing, i. e., 90 minutes of electrofocusing, and stan-
dard-resolution isoelectric focusing, i. e., 75 minutes of
electrofocusing. Isoelectric focusing resolves alkaline
phosphatase into at least 12 distinct fractions to which
specific organ sources have been assigned. In addition
to the 12 fractions seen in healthy individuals, other
fractions may be present in certain conditions; in preg-
nancy, the placental and a fetal intestinal forms are seen.
In AIDS-related Kaposi's sarcoma, a characteristic ab-
normal fraction ("ALP-k)" is seen.
After 75 minutes of migration, alkaline phosphatase
fractions la and Ib in normal individuals are easily dis-
cernable with alkaline phosphatase-Ib usually having
double the staining intensity of alkaline phosphatase-la.
Alkaline phosphatase fraction 2, which appears as three
fractions (alkaline phosphatase-2a, 2b and 2c) after 90
minutes of electrofocusing, is usually a single broad
band at 75 minutes. Alkaline phosphatase-2 is one of
the three most intensely-stained fractions in the alkaline
phosphatase pattern of healthy adults. With the excep^
tion of alkaline phosphatase-7a and 7b, which form an
equal-intensity doublet, alkaline phosphatase fractions 3
through 12 are singlets. Alkaline phosphatase-5 stands
out as a landmark in normals because of its intensity
and the relatively large distance between it and alkaline
phosphatase-4. Alkaline phosphatase-6 lies close to al-
kaline phosphatase-7a, is light in staining intensity, and
comprises about 2 to 3 U/l in sera from healthy individ-
uals. Alkaline phosphatase-10 is usually one of the dark-
est fractions, being greater than or equal to alkaline
phosphatase-2 in activity. Alkaline phosphatase-12 has
a distinctive orange-brown color that distinguishes it







































Fig. 1 Alkaline phosphatase fractionation.
a) All 12 major bands and some sub-bands.
b) Schematic of the alkaline phosphatase fractions with normal,
75 min, or high-resolution, 90 min, isoelectric focusing. The
dashed line indicates the location of the unusual fraction, named
ALP-k,^ that was found in some individuals with AlDS-associated
Kaposfs sarcoma. Lipoprotein-alkaline phosphatase, when present,
appears as an outline of the application mask over alkaline phos-
phatase fractions 7, 8, and 9; it is indicated with the vertical lines
in "b.". The anode (+) is at the top.
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unknown. In total, the 12 alkaline phosphatase fractions
range from a pi of 3.01 to 4.86 and span a length of
about 3.5 cm on the gel following 75 minutes of electro-
focusing.
The point at which bands split with increasing electrofo-
cusing time was determined by isoelectric focusing of
the pooled serum used for run-to-run quality control in
gels focused from 70 to 100 minutes in five-minutes
increments. With two exceptions, each split resulted in
subfractions of equal staining intensity. There was no
change in the appearance in alkaline phosphatase-la and
alkaline phosphatase-Ib at 90 minutes of electrofocus-
ing. Fraction 2 divided into three bands; alkaline phos-
phatase-2a gave a lightly stained band while alkaline
phosphatase-2b and alkaline phosphatase-2c were of
equal staining intensity but darker. Alkaline phosphatase
fractions 3,4, 8, 9, 10 and 11 split into doublets of equal
staining intensity. The appearance of alkaline phospha-
tase-6, alkaline phosphatase-7 and alkaline phosphatase-
12 was unchanged at 90 minutes of focusing vs. 75 min-
utes. Alkaline phosphatase-5 usually split into equal-in-
tensity doublets; in some cases, however, alkaline phos-
phatase-5a and alkaline phosphatase-5b did not match in
staining intensity. In these cases, there seems to be a
correlation between the alkaline phosphatase-2 activity
and the appearance of a darker alkaline phosphatase-5b.
The reason for this finding is unknown. The utility of
the high resolution pattern is uncertain because no
meaning has been assigned to all the subfractions and
the extent to which these subfraction may be artifactual
is unknown.
Electrofocusing time
The length of electrofocusing time is an important factor
in obtaining acceptable resolution. Although isoelectric
focusing is by nature an end-point or concentrating tech-
nique, subtle changes in the patterns occur after the frac-
tions have reached their isoelectric point. If the gel is
properly prepared and the specimens have a low salt
concentration, these changes are usually owing to catho-
dal endosmotic drift, termed "stretching," that has the
effect of lengthening the pH gradient in the region of
the gel where alkaline phosphatase-1 through alkaline
phosphatase-12 migrate. Most of the stretching occurred
in the alkaline phosphatase-5 to alkaline phosphatase-12
and to a lesser extent in the alkaline phosphatase-1
through alkaline phosphatase-4 region; this is shown in
figure 2. We found the optimal electrofocusing time to
be about 75 minutes, and this allowed the clear separa-
tion of all 12 alkaline phosphatase fractions with some
sub-fraction of alkaline phosphatase-1 and 2.
Reprödücibility
Between-run reproducibility of the alkaline phosphatase
fractions determined by isoelectric focusing was as-
sessed by repeatedly analyzing a pool of fresh serum
having an alkaline phosphatase activity of 187 U/l; the
data are in table 1. The pool had no apparent activity of
alkaline phosphatase bands 11 and 12.
Specimen stability
The between-run control demonstrated that alkaline
phosphatase fractions are stable for at least one month
while stored at -20 °C. Stability at 4 °C was tested by
storing three freshly prepared serum pools having nor-
mal, slightly increased and substantially increased alka-
line phosphatase activities. One aliquot from each alka-
line phosphatase pool was held at 4 °C for varying num-
bers of days as shown in table 2. A slight but significant
upward trend was present for the lowest activity pool
(p < 0.05). For the two higher-activity pools, the total
alkaline phosphatase did not change significantly
(p > 0.05) during the 32 days of storage at 4 °C. Others
reported recently that alkaline phosphatase is stable at
9 °C for at least seven days (5).
Freeze-thaw stability
The freeze-thaw stability of the total alkaline phospha-
tase and its isoforms was tested by subjecting two dif-
ferent pooled specimens to repeated cycles of freezing
and thawing. A freeze-thaw cycle was defined as expo-
sure to room temperature (22 °C to 26 °C) for 20 min-
utes to allow complete melting of the specimen followed
by storage in the freezer (—20 °C) for 30 minutes. As
shown in table 3, 64 freeze-thaw cycles had little effect
on the total alkaline phosphatase activity of the two
specimens. The isoelectric focusing results shown in fig-
ure 3 demonstrate that the individual alkaline phospha-
tase fractions are also resistant to degradation from re-
peated freezing and thawing.
S
70 75 90 95
Electrofocusing time [min]
100
Fig. 2 Cathodal drift of alkaline phosphatase fractions with
increasing electrofocusing time relative to fraction la. The alkaline
phosphatase fractions from bottom to top are Ib, 2, 3, 4, 5, 6, 7,
8,9, 10, 11, and 12.
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la lb 2 3 4 5 6 7 8 9 10
135 4.32 · 22.0 8.18 12.8 15.1 2.30 13.8 7.88 17.2 77.0
0.64 1.81 4.70 2.05 4.25 3.35 1.04 3.35 2.08 1.52 12.4
a All values in U/l. The alkaline phosphatase activity of the frac-
tions was calculated by multiplying the total activity by the percent
of the fraction obtained by densitometry. The pool of fresh sera
from patients and used here had no detectable alkaline phospha-
tase-11 or 12.
Phospholipase-C and sialidase treatment
of serum
We found the best resolution of the alkaline phosphatase
isoforms by working with neat, untreated serum. Phos-
phatidylinositol-specific phospholipase C enzymatically
cleaves the membrane-bound and hepatocellular alkaline
phosphatase fractions la, lb and 2 from the lipoprotein-
alkaline phosphatase complex. The lipoprotein-alkaline
phosphatase fraction does not migrate during isoelectric
focusing and appears as the image of the application
mask that appears on the gel as a smudge over alkaline
phosphatase fractions 7 through 9. Following treatment
with phospholipase-C, the staining intensity of the lipo-
protein-alkaline phosphatase disappears while fraction
la, lb and 2 are increased as is demonstrated in figure 4.
Sialidase enzymatically removes the sialic acid residues
attached during the post-translational modification of al-
Tab. 2 Results of alkaline phosphatase storage stability at 4 °C in
fresh pooled patients' sera.
































a Alkaline phosphatase activity prior to the start of the experiment.
Alkaline phosphatase values in table expressed as U/l. Specimen A
showed a statistically significant increase in the alkaline phospha-
tase with time, p < 0.05, whereas specimens B and C did not,
p > 0.05.



























kaline phosphatase. Differential sialidation of the tissue
nonspecific isoforms results in differences in their size
and charge and is the basis of the separation by isoelec-
8 16 32 64 N
b N
^gg^i ι
8 16 32 64
Fig. 3 Isoelectric focusing of the freeze-thaw aliquots. The upper
gel, "a", and the lower gel, "b", show the results of repeated freeze-
thaw cycles on specimen A (top) with ca. 200 U/l and B (bottom)
with ca. 150 U/l alkaline phosphatase activity. From left to right,
the number of cycles are 0, 2, 4, 8, 16, 32, and 64. The right-most
specimen in "a" and left-most specimen in "b" is a control lane
containing freshly collected serum from a healthy individual; it was
not subjected to freeze-thaw cycles. The anode (+) is at the top.
a See text for description of experiment.
Fig. 4 Effect of phospholipase-C treatment on the lipoprotein-al-
kaline phosphatase complex prior to isoelectric focusing. From left
to right, lanes 1, 3 and 5 are untreated specimens; lanes 1 and 3
show trace amounts of lipoprotein-bound alkaline phosphatase, and
lane 5 shows a marked increase. Lanes 2, 4 and 6 are replicates of
lanes 1, 3 and 5 except that, prior to isoelectric focusing they were
treated with phospholipase C. In each of the treated specimens, no
or little lipoprotein-alkaline phosphatase activity remained, while
alkaline phosphatase-la, lb and 2 were increased slightly The an-
ode (+) is at the top.
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trie focusing. By contrast, germ cell, intestinal and
placental alkaline phosphatases have different isoelec-
tric points owing to different amino acid sequences.
In theory, after the complete hydrolysis of the sialic
acid residues of alkaline phosphatase with sialidase,
isoelectric focusing should reveal only one fraction for
the tissue non-specific forms located at the normal
site for intestinal alkaline phosphatase. The position
of intestinal alkaline phosphatase is unaffected, be-
cause this fraction lacks sialic acid residues and is
sialidase resistant.
Sialidase treatment affected alkaline phosphatase frac-
tions 1 to 9 as expected; however, the resultant com-
bined fraction migrated to a position 6 to 7 mm cathodal
to the position of the untreated intestinal alkaline phos-
phatase, i.e., to the position of fraction 12. Sialidase did
not effect alkaline phosphatase fractions 10 or 11 that
remained in the same location as the untreated speci-
men. Sialidase treatment shifted alkaline phosphatase-
12 to a position 2 to 3 mm towards the cathode. This
phenomenon is shown in figure 5. Owing to the loss of
information caused by sialidase, we elected not to use
this technique.
Data Analysis and Discussion
Descriptive statistics and T-test evaluat ion
of all groups
Means and standard deviations of the tests for the dis-
ease groupings are given in table 4, and any statistically
significant differences between the diseased and control
Fig. 5 Effect of sialidase1) treatment prior to isoelectric focusing.
From left to right, lanes 1, 3 and 5 are untreated specimens. Lanes
2, 4 and 6 are replicates of lanes 1, 3 and 5 except that, prior to
isoelectric focusing, they were treated with sialidase. The treated
lane represents the enzymatic desialidation of alkaline phosphatase
fractions 1 through 8 which migrate cathodal to alkaline phospha-
tase-12 and are represented by the large, intensely stained fraction
at the bottom of lanes 2, 4 and 6. Note that sialidase does not effect
the position of alkaline phosphatase fractions 10 and 11, while the
position of alkaline phosphatase-12 has shifted slightly towards the
cathode. The anode (+) is at the top.
groups are given as well. Note that we divided alkaline
phosphatase-1 into fractions la and Ib, because we
found that fraction 1 splits into two, easily resolvable
fractions with the Isolab system. In patients with
lesions affecting primarily the biliary tract, e.g., pri-
mary biliary cirrhosis, primary sclerosing cholangitis,
and granulomatous hepatitis, we found marked in-
creases of most of the common liver-function tests;
alkaline phosphatase fractions la, and (or) Ib were
generally much higher than those of the other liver
disease groups. In patients with major hepatocyte in-
volvement, e.g., viral, granulomatous, or autoimmune
hepatitis, alkaline phosphatase-2, 3, 4 and 10 were
usually increased, sometimes dramatically so. Those
patients with biliary tract disorders also showed in-
creases in alkaline phosphatase 2, 3, 4, and 10; it
is reasonable to conclude that these individuals had
hepatocyte involvement as well in their disorder. Alka-
line phosphatase-10 may be a marker of T-cell infiltra-
tion; however, we found that the test is sensitive but
not specific for an autoimmune reaction.
T-test evaluation of selected groups
We chose a subset of our patients having alcoholic cir-
rhosis, primary biliary cirrhosis, or primary sclerosing
cholangitis to determine if any of the 10 tests in table 5
could be used to discriminate between these disorders
and if statistically significant findings were present. Pri-
mary biliary cirrhosis and primary sclerosing cholangitis
could not be distinguished using any of the tests in table
5 with the exception of alanine aminotransferase. By
contrast, most of the tests in table 5 show statistically
different results (p < 0.05) for primary biliary cirrhosis
and primary sclerosing cholangitis as compared to alco-
holic cirrhosis.
Another subset of 68 patients included 43 patients with
chronic hepatitis and 25 patients with chronic-active
hepatitis A, B, or C. T-test comparison of patients in
these two groups were made, and three tests showed
significant differences: alkaline phosphatase, p < 0.001;
total bilirubin, p < 0.003; and alkaline phosphatase-10,
p < 0.001.
Neural networks
Kazmierczak et al. applied neural networks for the
analysis of multivariate data (6). We elected to use
the same approach with a neural networks program
(Braincel V. 2, Promised Land Technologies, Inc., New
Haven, CT 06510 USA) on a MS-DOS 486DX2 per-
sonal computer. We wanted to learn which group of
tests gave the best discrimination between the 43 pa-
tients with chronic hepatitis and the 25 with chronic-
active viral hepatitis. We chose these two groups ow-
ing to the similarity of the disorders and because we
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Tab. 5 Correlation of laboratory tests in patients with three types of cirrhosis.






Alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase,
alkaline phosphatase-la, Ib, 2, 3, 4
Alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase,
alkaline phosphatase-la, Ib, 2, 3, 4, 10
Alanine
aminotransferase
Tests shown had p < 0.05 in comparing any two disease groups.
For example, in comparing primary biliary cirrhosis and alcoholic
cirrhosis, alkaline phosphatase, alanine aminotransferase, aspartate
aminotransferase, alkaline phosphatase-la, Ib, 2, 3, and 4 were
significantly different in patients with these diagnoses.
had data from a fairly large number of patients. We
used 34 of these subjects, randomly drawn, as the
training set for the neural networks "expert." Briefly,
the neural networks expert was trained so that a case
of chronic-active hepatitis would predict a "0" as the
output neuron, and chronic hepatitis would predict a
"1" as the output neuron. These outcome assignments
were made by us and are arbitrary; however, integer
values are usually assigned to output neurons. We
trained the expert to a 1% error rate; in all cases, the
training time on the personal computer was < 5 min.
In four separate trials, the training input neurons were:
1. Serum alkaline phosphatase, alanine aminotransfer-
ase, aspartate aminotransferase and total bilirubin;
2. Serum alkaline phosphatase fractions la, Ib, 2, 3, 4,
5, and 10;
3. All 11 of the tests in trials 1 and 2; and
4. Alkaline phosphatase, total bilirubin, and alkaline
phosphatase-10. Having now trained the expert, we cal-
culated the output neuron values for the above four trials
in the remaining 34 patients; these of course were not
part of the training set. The success of the expert in
predicting the correct diagnosis is shown in table 6. Out-
put neuron values of ± 0.2 of the expected values, i. e.,
0 to 0.2 for chronic-active hepatitis and 0.8 to 1.2 for
chronic hepatitis, were called "correct." The best combi-
nation of tests for discriminating between chronic and
chronic-active hepatitis was alkaline phosphatase, alka-
line phosphatase-10, and total bilirubin. The other com-
binations of tests were only slightly inferior. For the
diagnosis of chronic-activity hepatitis, the accuracy of
the neural networks output were practically the same for
the four test groups.
We also prepared receiver operating characteristic
curves (ROC) as was done by others (7) for the above
combinations of tests. The areas under the curves for the
four cases were not statistically different and were in the
range of 0.87 and 0.92. Several patients with a diagnosis
of chronic or chronic-active hepatitis were outliers on
two or more of the four sets of test combinations sug-
gesting the possibility of an incorrect classification.
Disease Staging with Alkaline Phosphatase by
Isoelectric Focusing
Patients with primary biliary cirrhosis (8) demonstrated
a consistent increase for alanine aminotransferase,
aspartate aminotransferase, alkaline phosphatase and to-
tal bilirubin regardless of the stage of the disease. Alka-
line phosphatase was increased in all of the 16 cases,
ranging from mild, i.e., 1.1 times the upper reference
limit, to grossly increased, i.e., 12.6 times the upper
reference limit. Alanine aminotransferase, aspartate ami-
notransferase and total bilirubin were increased in most
Tab. 6 Ability of neural networks to distinguish chronic-active from chronic hepatitis.




Alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, 83%b
total bilirubin
Alkaline phosphatase-la, Ib, 2, 3, 4, 10 75%
All in above two groups 83%





a Patients were in "predict" output group, not in "training" group. b A "correct" diagnosis was defined as having a neural network
There were 12 patients in chronic-active hepatitis predict group, predict output between 0 and 0.2 for chronic-active hepatitis or an
and 22 in chronic hepatitis predict group. output between 0.8 and 1.2 for chronic hepatitis.
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cases with the average increase being about twice the
upper reference limit. We found no relationship between
the activity of alanine aminotransferase and aspartate
aminotransferase and disease stage, whereas total alka-
line phosphatase and total bilirubin showed a correlation
in stages I through III but not in stage IV.
Alkaline phosphatase fractions la, Ib, 2, 3, 4 and 10
suggest the biochemical derangement that corresponds
to the underlying pathology and histological characteris-
tic of each stage of primary biliary cirrhosis. In stage I,
there is random, florid, focal destruction of the septal
and interlobular bile ducts that are surrounded by a
dense infiltrate of lymphocytes, both helper and suppres-
sor populations. The inflammatory reaction is largely
confined to the portal triads. Cholestasis begins to ap-
pear at this stage. Alkaline phosphatase fractions con-
firm the florid duct lesions with increase in the liver
cell fractions alkaline phosphatase-2, 3, and 4. A mild
increase in alkaline phosphatase-10 was consistent with
a focal-T-cell infiltrate.
In stage II the ductal involvement is more global, with
a reduction in the number of normal bile ducts and their
replacement with bizarre forms. The inflammatory in-
filtrate extends beyond the portal triads into the sur-
rounding parenchyma with destruction of some cells in
the limiting plates. In the periportal regions, ductular
proliferation creates tangled knots and strands of epithe-
lium devoid of lumina. Cholestasis is more evident dur-
ing this stage. The increase in alkaline phosphatase-2, 3,
and 4 in stage II disease corresponds to the global ductal
involvement and increasing Cholestasis. The presence of
increased alkaline phosphatase-10 is indicative of the
increase in both the number and distribution of the
chronic T-cell infiltrates.
In stage III, the inflammatory infiltrate is less prominent
and is replaced by fibrous septa that may interconnect
portal areas to create micronodules. There is a distinct
reduction in the number of bile ducts. The Cholestasis at
this stage is more marked than in stages I and II. The
profound Cholestasis is apparent in the striking increase
in liver cell alkaline phosphatase-2, 3, and 4. A reduc-
tion in the alkaline phosphatase-10 activity probably re-
flects the less prominent nature of the inflammatory
cell infiltrate.
In stage IV the fibrous septa have uniformly bridged the
portal areas enclosing individual lobules creating overt
micronodular cirrhosis. There is a scant lymphocytic in-
filtrate within the fibrous strands. Larger bile ducts have
virtually disappeared and Cholestasis is severe. The
increase in alkaline phosphatase-2, 3, and 4 and the
decrease of alkaline phosphatase-10 reflects the cirrhotic
state and the scant chronic cell infiltrates, respectively.
Figure 6 shows the distinct alkaline phosphatase isoform
pattern for each stage of primary biliary cirrhosis.
Primary sclerosing cholangitis
Primary sclerosing cholangitis shows a moderate to sub-
stantial increase in liver-function tests in nearly all
cases, a pattern similar to that seen in primary biliary
cirrhosis. Alkaline phosphatase is four times the upper
reference limit. This is illustrated in table 4. Primary
biliary cirrhosis is marked by a segmental, random and
uneven chronic fibrosing inflammatory reaction involv-
ing single or varying combinations of the extrahepatic
and intrahepatic bile ducts, and less commonly the pan-
creatic duct. The intrahepatic ductal lumina may be en-
tirely obliterated leaving only a fibrous scar; in the re-
gions proximal to the narrowing, there may be ductal
dilatation. A mononuclear inflammatory infiltrate is ac-
companied by occasional neutrophils and eosinophils.
The marked increase in the liver cell fractions, alkaline
phosphatase-1, 2, 3, and 4 correlates with the chronic
fibrosing condition. Although mild, the average increase
in alkaline phosphatase-10 corresponds to the chronic
inflammatory infiltrate.
Granulomatous hepatitis
All patients with granulomatous hepatitis had an
increased alkaline phosphatase ranging from a slight
increase in one case to between three- and eight-times
the upper reference limit in the remaining cases. With
the exception of one patient who had slightly increased
transaminases and total bilirubin, all patients had normal
values for alanine aminotransferase, aspartate amino-
transferase and alkaline phosphatase. Isoelectric focus-
ing showed a consistent and distinctive pattern of
grossly increased fractions la, Ib, 2, 3, and 4, while
alkaline phosphatase-10 was within the upper reference
limit or slightly increased. The lipoprotein-alkaline
phosphatase fraction was present in every case; the sig-
nificance of this is unknown. In the single case with
Fig. 6 Isoelectric focusing patterns of four stages of primary bili-
^C^°f[S' Uft t0 rigth' lane !* staSe [> aUcaline Phosphatase
135 U/l; lane 2, stage II, alkaline phosphatase 165 U/l; lane 3
stage III, alkaline phosphatase 685 U/l; lane 4, stage IV alkaline
phosphatase 774 U/l; lane 5, end-stage primary biliary cirrhosis,
alkaline phosphatase 397 U/l; lane 6, normal control, alkaline phos-
phatase 58 U/l. The anode (+) is at the top
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increased alanine aminotransferase, aspartate amino-
transferase and total bilirubin, the medical record indi-
cated that the patient also had "mild Crohn's disease"
and esophageal varices. A possible explanation for this
finding is presented by Greenstein (9) who found that in
about 5% of cases otCrohn's disease and ulcerative coli-
tis, there was concomitant hepatocellular disease.
Autoimmune hepatitis
As a group, patients with autoimmune hepatitis showed
variable isoelectric focusing results. However, when cat-
egorized by their disease stage, either chronic or
chronic-active, a consensus was noted between their
clinical and isoelectric focusing data. Patients in the
chronic subgroup showed within-upper reference limit
to mildly increased alkaline phosphatase values. A more
prominent, although variable, increase was noted for ala-
nine aminotransferase, aspartate aminotransferase and
total bilirubin with transaminases ranging from within
reference to seven times the upper reference limit. The
patients with increased total bilirubin were also those
with increased transaminases. Marked increases were
present for fractions 2, 3, 4, and 10; the latter suggests
a lymphocyte infiltrate.
Patients in the chronic-active hepatitis subgroup showed
a different pattern of results than those in the chronic sub-
group. Alkaline phosphatase activity was increased in all
cases to roughly twice the upper reference limit. Transam-
inases were extremely variable, ranging from within refr
erence in about one-half of the patients, to slightly
increased in one quarter, to grossly increased in the re-
maining patients.-The maximum alanine aminotransfer-
ase and aspartate aminotransferase values, 925 U/l and
1416 U/l, respectively, were found in this subgroup.
Autoimmune hepatitis has the morphologic appearance
of viral hepatitis, and as such is characterized in the
chronic stage as mild inflammation of the portal triads.
The chronic-active stage is characterized by extensive
portal inflammation that spills out of the portal tracts
into the periportal parenchyma by piecemeal bridging
necrosis. The isoelectric focusing data supports the his-
tologic findings for these two stages. Chronic autoim-
mune hepatitis has an alkaline phosphatase pattern that
is similar to chronic hepatitis C, except that alkaline
phosphatase-2 is increased to a greater degree in the au-
toimmune disease. The pattern of chronic-active autoim-
mune hepatitis is also similar to that of chronic-active
hepatitis C except that alkaline phosphatase fractions la,
Ib, 2 and 3 are more prominent in the autoimmune dis-
ease, while alkaline phosphatase-10 is more promiment
in the viral disease.
Steatohepatit is
The patients in the Steatohepatitis group had liver dis-
eases of varying origin. Despite the variety of diseases
that are present, they share the common histological
finding of moderate macrovesicular fatty change. Ala-
nine aminotransferase, aspartate aminotransferase, alka-
line phosphatase and total bilirubin are increased in
about half of the patients with increases limited to < 2
times the upper reference limit for each test. Total biliru-
bin was within the upper reference limit for all cases.
Conclusions
Isoelectric focusing of the multiple molecular forms of
alkaline phosphatase is a simple technique and is no
more difficult than ordinary protein electrophoresis (10).
The isoelectric focusing method described here gives
more information than heat inactivation or ordinary elec-
trophoresis (11) and is superior to older isoelectric fo-
cusing techniques described elsewhere (12, 13). Grif-
fith's assignment of alkaline phosphatase fractions la
and Ib as having a duct or ductule origin was confirmed
by our finding of marked increases of these fractions in
patients with primary biliary cirrhosis, primary scleros-
ing cholangitis, and granulomatous hepatitis. Alkaline
phosphatase Ib was also increased in most of the pa-
tients with autoimmune disorders; la and Ib were nor-
mal or only slighly increased in those with viral hepati-
tis, alcoholic cirrhosis or Steatohepatitis. Fractions 2, 3,
and 4 that are believed to reflect hepatocyte injury are
sensitive but non-specific markers; they were abnor-
mally increased in nearly all of our patients with chronic
liver diseases. Alkaline phosphatase fraction 10, is a sen-
sitive but non-specific test for lymphocyte infiltration; it
showed the highest values in chronic-active hepatitis,
especially in hepatitis C, cryptogenic cirrhosis, alcoholic
cirrhosis, primary biliary cirrhosis, primary sclerosing
cholangitis, and autoimmune hepatitis.
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